...
首页> 外文期刊>Journal of Medicinal Chemistry >Bispecific Estrogen Receptor a Degraders Incorporating Novel Binders Identified Using DNA-Encoded Chemical Library Screening
【24h】

Bispecific Estrogen Receptor a Degraders Incorporating Novel Binders Identified Using DNA-Encoded Chemical Library Screening

机译:双特异性雌激素受体掺入使用DNA编码的化学文库筛选鉴定的新粘合剂的降解剂

获取原文
获取原文并翻译 | 示例
           

摘要

Bispecific degraders (PROTACs) of ER alpha are expected to be advantageous over current inhibitors of ER alpha signaling (aromatase inhibitors/SERMs/SERDs) used to treat ER+ breast cancer. Information from DNA-encoded chemical library (DECL) screening provides a method to identify novel PROTAC binding features as the linker positioning, and binding elements are determined directly from the screen. After screening similar to 120 billion DNA-encoded molecules with ER alpha WT and 3 gain-of-function (GOF) mutants, with and without estradiol to identify features that enrich ER alpha competitively, the off-DNA synthesized small molecule exemplar 7 exhibited nanomolar ER alpha binding, antagonism, and degradation. Click chemistry synthesis on an alkyne E3 ligase engagers panel and an azide variant of 7 rapidly generated bispecific nanomolar degraders of ER alpha, with PROTACs 18 and 21 inhibiting ER+ MCF7 tumor growth in a mouse xenograft model of breast cancer. This study validates this approach toward identifying novel bispecific degrader leads from DECL screening with minimal optimization.
机译:与目前用于治疗ER+乳腺癌的ER-α信号抑制剂(芳香化酶抑制剂/SERM/SERD)相比,ER-α的双特异性降解物(PROTAC)有望发挥优势。来自DNA编码化学库(DECL)筛选的信息提供了一种方法来识别新的PROTAC结合特征,作为连接子定位,结合元素直接从筛选中确定。在筛选了类似于1200亿DNA编码分子的ERαWT和3功能增益(GOF)突变体(含和不含雌二醇)以确定竞争性富集ERα的特征后,非DNA合成的小分子样本7表现出纳摩尔ERα结合、拮抗和降解。点击炔烃E3连接酶接合器面板上的化学合成,以及7种快速生成的ERα双特异性纳摩尔降解物的叠氮化物变体,在小鼠异种乳腺癌移植模型中,PROTACs 18和21抑制ER+MCF7肿瘤生长。这项研究验证了这种方法,可以通过最小优化从DECL筛选中识别新的双特异性降解剂线索。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号